494799-17-6

Basic information

• Product Name: 3-cyclohexylindole-6-carboxylicacid
• Synonyms: 3-cyclohexylindole-6-carboxylicacid;1H-Indole-6-carboxylic acid, 3-cyclohexyl-;3-Cyclohexyl-6-indolecarboxylic acid;3-Cyclohexane-1H-indole-6-carboxylic acid
• CAS NO: 494799-17-6
• Molecular Formula: C₁₅H₁₇NO₂
• Molecular Weight: 243.304
• Mol File: 494799-17-6.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 486.3 °C at 760 mmHg
• Flash Point: 247.9 °C
• Appearance: /
• Density: 1.243 g/cm³
• Vapor Pressure: 2.87E-10mmHg at 25°C
• Refractive Index: 1.649
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-cyclohexylindole-6-carboxylicacid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-cyclohexylindole-6-carboxylicacid(494799-17-6)
• EPA Substance Registry System: 3-cyclohexylindole-6-carboxylicacid(494799-17-6)

Safety Data

• Hazardous Substances Data: 494799-17-6(Hazardous Substances Data)

Usage

Uses

3-Cyclohexyl-1H-indole-6-carboxylic Acid is used as a reactant in the preparation of dibenzo[b,f][1,4]thiazepinecarboxamides as hepatitis B core protein modulators.

InChI:InChI=1/C15H17NO2/c17-15(18)11-6-7-12-13(9-16-14(12)8-11)10-4-2-1-3-5-10/h6-10,16H,1-5H2,(H,17,18)

Upstream product

• 494799-18-7 methyl 3-cyclohexyl-1H-indole-6-carboxylate 
• 108-94-1 cyclohexanone 
• 50820-65-0 indole-6-carboxylic acid methyl ester 
• 1670-82-2 Indole-6-carboxylic acid 
• 494799-16-5 3-(cyclohex-1-en-1-yl)-1H-indole-6-carboxylic acid 

Downstream Products

• 494799-18-7 methyl 3-cyclohexyl-1H-indole-6-carboxylate 
• 1251033-29-0 3-cyclohexyl-N-(N,N-dimethylsulfamoyl)-1H-indole-6-carboxamide 
• 877270-31-0 5H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-6-(4-morpholinylcarbonyl)methyl ester 
• 1038924-00-3 7H-indolo[2,1-a][2]benzazepine-6,10-dicarboxylic acid, 13-cyclohexyl-3-methoxy-, 10-(1,1-dimethylethyl) ester 
• 928844-30-8 13-cyclohexyl-3-methoxy-7H-indolo[2,1-a][2]benzazepine-6,10-dicarboxylic acid 10-(1,1-dimethylethyl) ester 6-methyl ester 
• 877271-71-1 methyl 13-cyclohexyl-6-(carboxy)-5H-indolo[2,1-a][2]-benzazepine-10-carboxylate 
• 1045704-98-0 13-cyclohexyl-7H-indolo[2,1-a][2]benzazepine-6,10-dicarboxylic acid 10-(1,1-dimethylethyl) 6-methyl ester 
• 1045705-05-2 8-cyclohexyl-N-((dimethylamino)sulfonyl)-11-(methyloxy)-1a-((4-morpholinyl(oxo)acetyl)amino)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide 
• 1045705-30-3 8-cyclohexyl-N-(dimethylsulfamoyl)-11-methoxy-1a-((4-morpholinylsulfonyl)amino)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide 
• 877291-09-3 13-cyclohexyl-3-(methyloxy)-10-((methyloxy)carbonyl)-7H-indolo[2,1-a][2]benzazepine-6-carboxylic acid 
• 877291-15-1 13-cyclohexyl-3-methoxy-7H-indolo[2,1-a][2]benzazepine-6,10-dicarboxylic acid, dimethyl ester 
• 902148-40-7 2-bromo-3-cyclohexyl-N-[(dimethylamino)sulfonyl]-1H-indole-6-carboxamide 
• 958002-14-7 6H-Isoindolo[2,1-a]indole-3-carboxamide, 11-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-ethoxy-8-methoxy- 

Relevant articles and documents

The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor

The process development and kilogram-scale synthesis of beclabuvir (BMS-791325, 1) is described. The convergent synthesis features the use of asymmetric catalysis to generate a chiral cyclopropane fragment and coupling with an indole fragment via an alkyl

CARBOXYL SUBSTITUTED INDOLES FOR USE AS PPAR ALPHA MODULATORS

There is provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof wherein one of R1 and R2 is H and the other is COOH. The compounds are useful as PPAR modulators.

Compounds for the Treatment of Hepatitis C

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.